Skip to content

Biologic Discovery
Partnership Model

Mosaic Biosciences partners with biopharma, biotechnology, and academic teams to deliver integrated biologics discovery capabilities that combine scientific expertise, proprietary technologies, and collaborative engagement models to advance programs efficiently from concept through candidate selection.

What Sets Mosaic Apart

Mosaic integrates biologics discovery services across scientific expertise and collaborative engagement models to advance programs with clarity and speed.

Keep every milestone on track


Solve complex challenges across biologic modalities


Guide discovery strategy and decision-making


Access additional capabilities when needed


Execute advanced experiments with precision


How We Uncover Opportunity

Mosaic Biosciences initiates biologic drug discovery programs through integrated target evaluation, modality alignment, and discovery strategy design and ensuring experimental direction is grounded in therapeutic objectives from the outset.

Broad domain knowledge spanning biologic discovery and engineering disciplines.


Each stage of discovery informs the next through connected workflows and integrated data.


Strategies adapt to new findings and evolving program priorities.


Mosaic Biosciences scientists analyzing biologic samples in discovery laboratory

How Mosaic Advances Discovery Programs

Mosaic advances biologics discovery programs through integrated antibody discovery, screening, engineering, and analytics workflows that enable rapid iteration, data-driven decision-making, and efficient progression toward optimized candidates.

  • 1. Program Initiation


    Project success starts with the right team, clear goals, and smart planning. We align on target biology and product profile, then build a focused discovery strategy and experimental plan with defined milestones, timelines, and costs.

  • 2. Discovery and Screening


    A dedicated team gets to work on the core scientific challenges. Our bioengineering, protein science, and antibody discovery experts collaborate using integrated in vitro and in vivo technologies to identify and evaluate the strongest targets and leads.

  • 3. Optimization and Selection


    We don’t just find proteins and antibodies, we shape them into drugs. Through engineering, functional characterization, and developability assessment, our teams refine candidates for stability, efficacy, specificity, and expression.

  • 4. In Vivo Pharmacology


    We don’t just run in vivo studies, we make them matter. We design key experiments, prepare high-quality materials, build tailored PK/PD assays, and deliver clear analytics to support confident program decisions.

Who We Work With

Mosaic collaborates with biopharma, biotechnology, and academic organizations as biologics discovery partners, supporting programs across therapeutic areas, modalities, and stages of development.

Biotech Companies


Emerging and growth-stage biotechnology teams developing novel biologic therapeutics and seeking integrated discovery expertise.

Biopharma Organizations


Discovery groups augmenting internal capabilities with Mosaic’s technologies, scientific teams, and program support.

Pharmaceutical Companies


Large R&D organizations pursuing biologic programs requiring specialized discovery technologies and flexible collaboration.

Academic and Research Institutions


Translational research teams advancing biologic candidates toward preclinical development.

Scientist handling a sample vial while loading a laboratory instrument for biologic discovery experiments.

Biologics Discovery Capabilities

Mosaic delivers biologics discovery services spanning antibody discovery, protein engineering, screening, and integrated analytics, supporting efficient progression from target assessment through candidate optimization.


Antibody Discovery

In vivo and in vitro discovery capabilities generate diverse antibody repertoires for screening and selection.


Protein Engineering

Molecular optimization improves affinity, specificity, stability, and developability.


Screening and Characterization

Biophysical and functional assays evaluate candidate performance and properties.


Integrated Analytics

Sequencing and data analysis inform selection and engineering decisions.

Advance Your Biologic Discovery Program

Connect with Mosaic scientists to discuss your biologics discovery program, targets, and collaboration goals.

Why Mosaic Biosciences

Mosaic Biosciences operates as a biologics discovery CRO partner, integrating proprietary technologies, scientific expertise, and collaborative engagement models to advance complex discovery programs with precision and efficiency.

Integrated Discovery Capabilities

Antibody discovery, protein engineering, screening, and analytics delivered through an integrated discovery model from target assessment through lead optimization.


Scientific Partnership Model

Direct collaboration with Mosaic scientists enables aligned decision-making, adaptive program design, and efficient progression.


Modality and Target Flexibility

Capabilities span challenging targets and diverse biologic modalities, enabling strategies tailored to program biology.


Speed with Data-Driven Decisions

Integrated analytics and real-time data interpretation accelerate progression while maintaining scientific rigor.

Scientist performing pipetting and sample preparation at a laboratory bench during biologics discovery research.

Engagement Models

Mosaic supports outsourced biologics discovery through flexible engagement models aligned to scientific goals, program stage, and organizational strategy.

Program-Based Partnerships


Dedicated discovery programs executed in close collaboration with Mosaic scientific teams, aligned to defined milestones and portfolio objectives.

Integrated Technology Access


Targeted use of Mosaic discovery technologies to augment internal capabilities, accelerate screening, or enable specialized modalities.

Collaborative Research


Joint scientific exploration of novel targets, modalities, or discovery approaches through shared experimental design and execution.

Lasting Relationships and Continued Support

Mosaic fosters long-term biologics discovery partnerships through sustained scientific collaboration, program continuity, and ongoing optimization support beyond initial discovery milestones.

Long-term scientific collaboration partnership

Long-term Scientific Collaboration
We build enduring partnerships aligned to program success and portfolio goals.

Flexible biologic discovery partnership model

Flexible Commercial Models
Milestone- and royalty-based discovery partnerships support shared program value.